The oral administration of prostigmin in the treatment of myasthenia gravis

被引：12

作者：

Viets, HR ^{[1
]}

Mitchell, RS ^{[1
]}

Schwab, RS ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA

来源：

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1937年 / 109卷

关键词：

D O I：

10.1001/jama.1937.02780500012004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1956 / 1959

页数：4

共 10 条

[1]

EVERTS WH, 1935, B NEUROL I NEW YORK, V4, P523

[2] The therapeutics of prostigmin - A warning concerning its oral use based on a personal experience [J].

Goodman, LS ;

Bruckner, WJ .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1937, 108 :965-968

[3]

Laurent LPE, 1936, LANCET, V1, P1457

[4]

McGeorge M, 1937, LANCET, V1, P69

[5] Experience with oral prostigmin therapy in myasthenia gravis [J].

Mitchell, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1937, 216 :96-97

[6]

Schneider ME, 1936, MON PSYCHIATR NEUROL, V94, P123

[7]

SMITH WA, 1937, J M A GEORGIA, V26, P26

[8] The therapeutics of prostigmin [J].

Thorner, MW .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1937, 108 :1449-1450

[9] Prostigmin in the diagnosis of myasthenia gravis [J].

Viets, HR ;

Schwab, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1935, 213 :1280-1283

[10] The prostigmin test in myasthenia gravis [J].

Viets, HR ;

Mithchell, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1936, 215 :1064-1065

← 1 →